Sphingosine-1-phosphate receptor 3 promotes leukocyte rolling by mobilizing endothelial P-selectin

Nature Communications

Volumn 6, Issue , 2015, Pages

  Nussbaum, Claudia ^a,b   Bannenberg, Sarah ^c   Keul, Petra ^c   Gräler, Markus H ^d   Gonçalves De Albuquerque, Cassiano F ^a,e   Korhonen, Hanna ^f   Von Wnuck Lipinski, Karin ^c   Heusch, Gerd ^c   De Castro Faria Neto, Hugo C ^e   Rohwedder, Ina ^a   Göthert, Joachim R ^c   Prasad, Vysakh Pushpa ^g   Haufe, Günter ^g   Lange Sperandio, Baerbel ^b   Offermanns, Stefan ^f   Sperandio, Markus ^a   Levkau, Bodo ^c  

^a UNIVERSITY OF MUNICH   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^c UNIVERSITY HOSPITAL ESSEN   (Germany)

^d JENA UNIVERSITY HOSPITAL   (Germany)

^e INSTITUTO OSWALDO CRUZ   (Brazil)

^f MAX PLANCK INSTITUTE FOR HEART AND LUNG RESEARCH   (Germany)

^g UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; CALCIUM ION; CYCLIC AMP; FINGOLIMOD; HISTAMINE; PADGEM PROTEIN; PHOSPHOLIPASE C; SPHINGOSINE 1 PHOSPHATE RECEPTOR; SPHINGOSINE 1 PHOSPHATE RECEPTOR 1; SPHINGOSINE 1 PHOSPHATE RECEPTOR 3; SPHINGOSINE KINASE 1; UNCLASSIFIED DRUG; CALCIUM; EDG3 PROTEIN, MOUSE; EPINEPHRINE; GUANINE NUCLEOTIDE BINDING PROTEIN ALPHA SUBUNIT; LYSOPHOSPHOLIPID; PHOSPHOLIPASE C BETA; PHOSPHOTRANSFERASE; SPHINGOSINE; SPHINGOSINE 1-PHOSPHATE; SPHINGOSINE KINASE; SPHINGOSINE-1-PHOSPHATE RECEPTOR-3, HUMAN;

CYTOLOGY; MICROSCOPY; MUSCLE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INHIBITION; HUMAN; HUMAN CELL; LEUKOCYTE ROLLING; MAST CELL; MICROSCOPY; MOUSE; NONHUMAN; PROTEIN FUNCTION; PROTEIN SECRETION; PROTEIN TRANSPORT; VASCULAR ENDOTHELIUM; ANALOGS AND DERIVATIVES; ANIMAL; GENETICS; IMMUNOHISTOCHEMISTRY; KNOCKOUT MOUSE; MALE; METABOLISM; SKELETAL MUSCLE; UMBILICAL VEIN ENDOTHELIAL CELL; VASCULARIZATION; VENULE;

MUS;

ANIMALS; CALCIUM; ENDOTHELIUM, VASCULAR; EPINEPHRINE; GTP-BINDING PROTEIN ALPHA SUBUNITS, GQ-G11; HISTAMINE; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; IMMUNOHISTOCHEMISTRY; LEUKOCYTE ROLLING; LYSOPHOSPHOLIPIDS; MALE; MAST CELLS; MICE; MICE, KNOCKOUT; MUSCLE, SKELETAL; P-SELECTIN; PHOSPHOLIPASE C BETA; PHOSPHOTRANSFERASES (ALCOHOL GROUP ACCEPTOR); RECEPTORS, LYSOSPHINGOLIPID; SPHINGOSINE; VENULES;

EID: 84926365657     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms7416     Document Type: Article

References (70)

1. Rivera, J., Proia, R. L. & Olivera, A. The alliance of sphingosine-1-phosphate and its receptors in immunity. Nat. Rev. Immunol. 8, 753-763 (2008).
2. Ledgerwood, L. G. et al. The sphingosine 1-phosphate receptor 1 causes tissue retention by inhibiting the entry of peripheral tissue T lymphocytes into afferent lymphatics. Nat. Immunol. 9, 42-53 (2008).
3. Keul, P. et al. Sphingosine-1-phosphate receptor 3 promotes recruitment of monocyte/macrophages in inflammation and atherosclerosis. Circ. Res. 108, 314-323 (2010).
4. Rivera, R. & Chun, J. Biological effects of lysophospholipids. Rev. Physiol. Biochem. Pharmacol. 160, 25-46 (2008).
5. McVerry, B. J. & Garcia, J. G. In vitro and in vivo modulation of vascular barrier integrity by sphingosine 1-phosphate: mechanistic insights. Cell Signal. 17, 131-139 (2005).
6. Tauseef, M. et al. Activation of sphingosine kinase-1 reverses the increase in lung vascular permeability through sphingosine-1-phosphate receptor signaling in endothelial cells. Circ. Res. 103, 1164-1172 (2008).
7. Camerer, E. et al. Sphingosine-1-phosphate in the plasma compartment regulates basal and inflammation-induced vascular leak in mice. J. Clin. Invest. 119, 1871-1879 (2009).
8. Xia, P. et al. Tumor necrosis factor-alpha induces adhesion molecule expression through the sphingosine kinase pathway. Proc. Natl Acad. Sci. USA 95, 14196-14201 (1998).
9. Kimura, T. et al. Sphingosine 1-phosphate receptors mediate stimulatory and inhibitory signalings for expression of adhesion molecules in endothelial cells. Cell Signal. 18, 841-850 (2006).
10. Krump-Konvalinkova, V. et al. Stable knock-down of the sphingosine 1- phosphate receptor S1P1 influences multiple functions of human endothelial cells. Arterioscler. Thromb. Vasc. Biol. 25, 546-552 (2005).
11. Limaye, V. et al. Chronic increases in sphingosine kinase-1 activity induce a pro-inflammatory, pro-angiogenic phenotype in endothelial cells. Cell Mol. Biol. Lett. 14, 424-441 (2009).
12. Kimura, T. et al. Role of scavenger receptor class B type I and sphingosine 1- phosphate receptors in high density lipoprotein-induced inhibition of adhesion molecule expression in endothelial cells. J. Biol. Chem. 281, 37457-37467 (2006).
13. Bolick, D. T. et al. Sphingosine-1-phosphate prevents tumor necrosis factor-{alpha}-mediated monocyte adhesion to aortic endothelium in mice. Arterioscler. Thromb. Vasc. Biol. 25, 976-981 (2005).
14. Whetzel, A. M. et al. Sphingosine-1 phosphate prevents monocyte/endothelial interactions in type 1 diabetic NOD mice through activation of the S1P1 receptor. Circ. Res. 99, 731-739 (2006).
15. Sattler, K. & Levkau, B. Sphingosine-1-phosphate as a mediator of high-density lipoprotein effects in cardiovascular protection. Cardiovasc. Res. 82, 201-211 (2009).
16. Sun, W. Y. et al. Rapid histamine-induced neutrophil recruitment is sphingosine kinase-1 dependent. Am. J. Pathol. 180, 1740-1750 (2012).
17. Sperandio, M., Gleissner, C. A. & Ley, K. Glycosylation in immune cell trafficking. Immunol. Rev. 230, 97-113 (2009).
18. Sperandio, M., Pickard, J., Unnikrishnan, S., Acton, S. T. & Ley, K. Analysis of leukocyte rolling in vivo and in vitro. Methods Enzymol. 416, 346-371 (2006).
19. Ley, K. The role of selectins in inflammation and disease. Trends Mol. Med. 9, 263-268 (2003).
20. Rossi, B. & Constantin, G. Anti-selectin therapy for the treatment of inflammatory diseases. Inflamm. Allergy Drug Targets 7, 85-93 (2008).
21. Impellizzeri, D. & Cuzzocrea, S. Targeting selectins for the treatment of inflammatory diseases. Expert Opin. Ther. Targets 18, 55-67 (2014).
22. Luo, W. et al. P-selectin glycoprotein ligand-1 inhibition blocks increased leukocyte-endothelial interactions associated with sickle cell disease in mice. Blood 120, 3862-3864 (2012).
23. Combes, V. et al. Pathogenic role of P-selectin in experimental cerebral malaria: importance of the endothelial compartment. Am. J. Pathol. 164, 781-786 (2004).
24. Sperandio, M. et al. Alpha 2,3-sialyltransferase-IV is essential for L-selectin ligand function in inflammation. Eur. J. Immunol. 36, 3207-3215 (2006).
25. Klinke, A. et al. Myeloperoxidase attracts neutrophils by physical forces. Blood 117, 1350-1358 (2010).
26. Rivera-Nieves, J. et al. Critical role of endothelial P-selectin glycoprotein ligand1 in chronic murine ileitis. J. Exp. Med. 203, 907-917 (2006).
27. Kunkel, E. J. et al. Absence of trauma-induced leukocyte rolling in mice deficient in both P-selectin and intercellular adhesion molecule 1. J. Exp. Med. 183, 57-65 (1996).
28. Mayadas, T. N., Johnson, R. C., Rayburn, H., Hynes, R. O. & Wagner, D. D. Leukocyte rolling and extravasation are severely compromised in P selectindeficient mice. Cell 74, 541-554 (1993).
29. Kubes, P. & Kanwar, S. Histamine induces leukocyte rolling in postcapillary venules. A P-selectin-mediated event. J. Immunol. 152, 3570-3577 (1994).
30. Nussbaum, C. et al. Neutrophil and endothelial adhesive function during human fetal ontogeny. J. Leukoc. Biol. 93, 175-184 (2013).
31. Frommhold, D. et al. RAGE and ICAM-1 cooperate in mediating leukocyte recruitment during acute inflammation in vivo. Blood 116, 841-849 (2010).
32. Murakami, A. et al. Sphingosine 1-phosphate (S1P) regulates vascular contraction via S1P3 receptor: investigation based on a new S1P3 receptor antagonist. Mol. Pharmacol. 77, 704-713 (2010).
33. van Mourik, J. A., Romani de Wit, T. & Voorberg, J. Biogenesis and exocytosis of Weibel-Palade bodies. Histochem. Cell Biol. 117, 113-122 (2002).
34. An, S., Bleu, T. & Zheng, Y. Transduction of intracellular calcium signals through G protein-mediated activation of phospholipase C by recombinant sphingosine 1-phosphate receptors. Mol. Pharmacol. 55, 787-794 (1999).
35. Sato, K. et al. Activation of phospholipase C-Ca2 + system by sphingosine 1-phosphate in CHO cells transfected with Edg-3, a putative lipid receptor. FEBS Lett. 443, 25-30 (1999).
36. Chun, J., Hla, T., Lynch, K. R., Spiegel, S. & Moolenaar, W. H. International Union of Basic and Clinical Pharmacology. LXXVIII. Lysophospholipid receptor nomenclature. Pharmacol. Rev. 62, 579-587 (2010).
37. Korhonen, H. et al. Anaphylactic shock depends on endothelial Gq/G11. J. Exp. Med. 206, 411-420 (2009).
38. Schwab, S. R. et al. Lymphocyte sequestration through S1P lyase inhibition and disruption of S1P gradients. Science 309, 1735-1739 (2005).
39. Sensken, S. C. et al. Selective activation of G alpha i mediated signalling of SIP(3) by FTY720-phosphate. Cell. Signal. 20, 1125-1133 (2008).
40. French, K. J. et al. Discovery and evaluation of inhibitors of human sphingosine kinase. Cancer Res. 63, 5962-5969 (2003).
41. Cleator, J. H., Zhu, W. Q., Vaughan, D. E. & Hamm, H. E. Differential regulation of endothelial exocytosis of P-selectin and von Willebrand factor by protease-activated receptors and cAMP. Blood 107, 2736-2744 (2006).
42. Rius, R. A., Edsall, L. C. & Spiegel, S. Activation of sphingosine kinase in pheochromocytoma PC12 neuronal cells in response to trophic factors. FEBS Lett. 417, 173-176 (1997).
43. Prieschl, E. E., Csonga, R., Novotny, V., Kikuchi, G. E. & Baumruker, T. The balance between sphingosine and sphingosine-1-phosphate is decisive for mast cell activation after Fc epsilon receptor I triggering. J. Exp. Med. 190, 1-8 (1999).
44. Jolly, P. S. et al. Transactivation of sphingosine-1-phosphate receptors by FcepsilonRI triggering is required for normal mast cell degranulation and chemotaxis. J. Exp. Med. 199, 959-970 (2004).
45. Olivera, A. & Rivera, J. An emerging role for the lipid mediator sphingosine-1-phosphate in mast cell effector function and allergic disease. Adv. Exp. Med. Biol. 716, 123-142 (2011).
46. Stokes, A. J., Shimoda, L. M., Koblan-Huberson, M., Adra, C. N. & Turner, H. A TRPV2-PKA signaling module for transduction of physical stimuli in mast cells. J. Exp. Med. 200, 137-147 (2004).
47. Zhang, D. et al. Mast-cell degranulation induced by physical stimuli involves the activation of transient-receptor-potential channel TRPV2. Physiol. Res. 61, 113-124 (2011).
48. Pan, S. et al. A monoselective sphingosine-1-phosphate receptor-1 agonist prevents allograft rejection in a stringent rat heart transplantation model. Chem. Biol. 13, 1227-1234 (2006).
49. Matsushita, K., Morrell, C. N. & Lowenstein, C. J. Sphingosine 1-phosphate activates Weibel-Palade body exocytosis. Proc. Natl Acad. Sci. USA 101, 11483-11487 (2004).
50. Florey, O. & Haskard, D. O. Sphingosine 1-phosphate enhances Fc gamma receptor-mediated neutrophil activation and recruitment under flow conditions. J. Immunol. 183, 2330-2336 (2009).
51. Allende, M. L. et al. Sphingosine-1-phosphate lyase deficiency produces a proinflammatory response while impairing neutrophil trafficking. J. Biol. Chem. 286, 7348-7358 (2010).
52. Zhao, Y. et al. Protection of LPS-induced murine acute lung injury by sphingosine-1-phosphate lyase suppression. Am. J. Respir. Cell Mol. Biol. 45, 426-435 (2010).
53. Peng, X. et al. Protective effects of sphingosine 1-phosphate in murine endotoxin-induced inflammatory lung injury. Am. J. Respir. Cell Mol. Biol. 169, 1245-1251 (2004).
54. Sawicka, E. et al. Inhibition of Th1- and Th2-mediated airway inflammation by the sphingosine 1-phosphate receptor agonist FTY720. J. Immunol. 171, 6206-6214 (2003).
55. Salomone, S. & Waeber, C. Selectivity and specificity of sphingosine-1- phosphate receptor ligands: caveats and critical thinking in characterizing receptor-mediated effects. Front. Pharmacol. 2, 9 (2011).
56. Nofer, J. R. et al. HDL induces NO-dependent vasorelaxation via the lysophospholipid receptor S1P(3). J. Clin. Invest. 113, 569-581 (2004).
57. Theilmeier, G. et al. High-density lipoproteins and their constituent, sphingosine-1-phosphate, directly protect the heart against ischemia/ reperfusion injury in vivo via the S1P(3) lysophospholipid receptor. Circulation 114, 1403-1409 (2006).
58. Frenette, P. S. et al. Platelet-endothelial interactions in inflamed mesenteric venules. Blood 91, 1318-1324 (1998).
59. Carvalho-Tavares, J. et al. A role for platelets and endothelial selectins in tumor necrosis factor-alpha-induced leukocyte recruitment in the brain microvasculature. Circ. Res. 87, 1141-1148 (2000).
60. Uemura, T. et al. Biological properties of a specific Galpha q/11 inhibitor, YM-254890, on platelet functions and thrombus formation under high-shear stress. Br. J. Pharmacol. 148, 61-69 (2006).
61. Niessen, F. et al. Dendritic cell PAR1-S1P3 signalling couples coagulation and inflammation. Nature 452, 654-658 (2008).
62. Rosen, H., Gonzalez-Cabrera, P. J., Sanna, M. G. & Brown, S. Sphingosine 1-phosphate receptor signaling. Annu. Rev. Biochem. 78, 743-768 (2009).
63. Cyster, J. G. & Schwab, S. R. Sphingosine-1-phosphate and lymphocyte egress from lymphoid organs. Annu. Rev. Biochem. 30, 69-94 (2011).
64. Imeri, F. et al. Novel oxazolo-oxazole derivatives of FTY720 reduce endothelial cell permeability, immune cell chemotaxis and symptoms of experimental autoimmune encephalomyelitis in mice. Neuropharmacology 85, 314-327 (2014).
65. Gossens, K. et al. Thymic progenitor homing and lymphocyte homeostasis are linked via S1P-controlled expression of thymic P-selectin/CCL25. J. Exp. Med. 206, 761-778 (2009).
66. Choi, J. W. et al. FTY720 (fingolimod) efficacy in an animal model of multiple sclerosis requires astrocyte sphingosine 1-phosphate receptor 1 (S1P1) modulation. Proc. Natl Acad. Sci. USA 108, 751-756 (2010).
67. Gothert, J. R. et al. Genetically tagging endothelial cells in vivo: bone marrow-derived cells do not contribute to tumor endothelium. Blood 104, 1769-1777 (2004).
68. Jensen, B. M., Swindle, E. J., Iwaki, S. & Gilfillan, A. M. Generation, isolation, and maintenance of rodent mast cells and mast cell lines. Curr. Protoc. Immunol. Chapter 3, Unit 3 23 (2006).
69. Drew, E., Merkens, H., Chelliah, S., Doyonnas, R. & McNagny, K. M. CD34 is a specific marker of mature murine mast cells. Exp. Hematol. 30, 1211-1218 (2002).
70. Sattler, K. J. E. et al. Sphingosine 1-phosphate levels in plasma and HDL are altered in coronary artery disease. Basic Res. Cardiol. 105, 821-832 (2010).